MetaSeminar

„Technology-enhanced therapy of eating and weight disorders“

Datum
18.07.2019 - 14:30 bis 16:00
Standort
Universitätsklinikum Leipzig
Liebigstraße 20, Haus 4, Glaskasten
Konferenzraum 0015/0016, Justus von Liebig
04103 Leipzig
Anmeldung
Keine Anmeldung erforderlich.

Liebe IFB-Mitglieder, Doktoranden/innen, Interessierte,

wir laden Sie recht herzlich zum nächsten MetaSeminar ein, der Veranstaltungsreihe des IFB AdipositasErkrankungen.
Interne und externe Referenten stellen Aktuelles aus der Adipositasforschung und –behandlung vor. Das MetaSeminar ermöglicht Fragen, Diskussionen und den Austausch mit Kolleginnen und Kollegen. Die wissenschaftliche Leitung der Veranstaltungsreihe übernimmt Prof. Michael Stumvoll.

„Technology-enhanced therapy of eating and weight disorders“
Referentin: Adrienne Juarascio, PhD, Department of Psychology, Drexel University, Philadelphia

Donnerstag, 18. Juli 2019, 14.30-16 Uhr
Veranstaltungsort: Universitätsklinikum Leipzig, Haus 4, Glaskasten (Konferenzraum 0015/0016, Justus von Liebig), Liebigstraße 20, Haus 4, UKL

Abstract:  Current standard behavioral interventions for obesity and related eating disorders have limited short- and long-term success, and their heterogeneous presentation and complex etiology and maintenance makes the development of personalized interventions necessary in order to support behavior change in a patient’s daily life. In her talk Technology-enhanced therapy of eating and weight disorders, Adrienne Juarascio, PhD, will present the state of the art of technology-enhanced treatment in obesity and related eating disorders, including smartphone-based just-in-time interventions. A further focus will be on the evaluation of mechanisms of action within behavioral treatments. Finally, she will address third-wave acceptance-based behavioral therapies and their potential for improving treatment outcome in obesity and related eating disorders. These informations are central for advancing evidence-based interventions such as cognitive-behavioral therapy for binge-eating disorder in adolescents (BEDA study, 01EO1001 K7-16) or behavioral weight loss treatment as used in the IFB Outpatient Unit (Doc Weight).